SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037775
Filing Date
2020-08-06
Accepted
2020-08-06 16:20:47
Documents
62
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgnx-10q_20200630.htm   iXBRL 10-Q 2806297
2 EX-31.1 rgnx-ex311_53.htm EX-31.1 16938
3 EX-31.2 rgnx-ex312_51.htm EX-31.2 16909
4 EX-32.1 rgnx-ex321_52.htm EX-32.1 11297
  Complete submission text file 0001564590-20-037775.txt   9956870

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20200630.xsd EX-101.SCH 44395
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgnx-20200630_cal.xml EX-101.CAL 54057
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgnx-20200630_def.xml EX-101.DEF 145256
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20200630_lab.xml EX-101.LAB 382884
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20200630_pre.xml EX-101.PRE 282082
10 EXTRACTED XBRL INSTANCE DOCUMENT rgnx-10q_20200630_htm.xml XML 2369723
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37553 | Film No.: 201082009
SIC: 2836 Biological Products, (No Diagnostic Substances)